Global Dihydroartemisinin Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Global Dihydroartemisinin Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Dihydroartemisinin Research Scope
1.2 Market Segment by Type
1.2.1 Global Dihydroartemisinin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Pharmaceutical Grade
1.2.3 Industrial Grade
1.3 Market Segment by Application
1.3.1 Global Dihydroartemisinin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Malaria Treatment
1.3.3 Scientific Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Market Production
2.1 Global Dihydroartemisinin Production Capacity (2017-2028)
2.2 Global Dihydroartemisinin Production by Region: 2017 VS 2021 VS 2028
2.3 Global Dihydroartemisinin Production by Region
2.3.1 Global Dihydroartemisinin Historic Production by Region (2017-2022)
2.3.2 Global Dihydroartemisinin Forecasted Production by Region (2023-2028)
2.3.3 North America
2.3.4 Europe
2.3.5 Japan
2.3.6 China
2.3.7 South Korea
2.3.8 India
2.4 Market Dynamics
2.4.1 Dihydroartemisinin Industry Trends
2.4.2 Dihydroartemisinin Market Drivers
2.4.3 Dihydroartemisinin Market Challenges
2.4.4 Dihydroartemisinin Market Restraints
3 Global Dihydroartemisinin Sales
3.1 Global Dihydroartemisinin Sales Estimates and Forecasts 2017-2028
3.2 Global Dihydroartemisinin Revenue Estimates and Forecasts 2017-2028
3.3 Global Dihydroartemisinin Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Top Dihydroartemisinin Regions by Sales
3.4.1 Global Top Dihydroartemisinin Regions by Sales (2017-2022)
3.4.2 Global Top Dihydroartemisinin Regions by Sales (2023-2028)
3.5 Global Top Dihydroartemisinin Regions by Revenue
3.5.1 Global Top Dihydroartemisinin Regions by Revenue (2017-2022)
3.5.2 Global Top Dihydroartemisinin Regions by Revenue (2023-2028)
3.5.3 North America
3.5.4 Europe
3.5.5 Asia-Pacific
3.5.6 Latin America
3.5.7 Middle East & Africa
4 Competition by Manufacturers
4.1 Global Dihydroartemisinin Production Capacity by Manufacturers
4.2 Global Dihydroartemisinin Sales by Manufacturers
4.2.1 Global Top Dihydroartemisinin Manufacturers by Sales (2017-2022)
4.2.2 Global Top Dihydroartemisinin Manufacturers Market Share by Sales (2017-2022)
4.2.3 Global Top 10 and Top 5 Companies by Dihydroartemisinin Sales in 2021
4.3 Global Dihydroartemisinin Revenue by Manufacturers
4.3.1 Global Top Dihydroartemisinin Manufacturers by Revenue (2017-2022)
4.3.2 Global Top Dihydroartemisinin Manufacturers Market Share by Revenue (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Dihydroartemisinin Revenue in 2021
4.4 Global Dihydroartemisinin Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Dihydroartemisinin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Dihydroartemisinin Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Estimates and Forecasts by Type
5.1 Global Dihydroartemisinin Sales by Type
5.1.1 Global Dihydroartemisinin Historical Sales by Type (2017-2022)
5.1.2 Global Dihydroartemisinin Forecasted Sales by Type (2023-2028)
5.1.3 Global Dihydroartemisinin Sales Market Share by Type (2017-2028)
5.2 Global Dihydroartemisinin Revenue by Type
5.2.1 Global Dihydroartemisinin Historical Revenue by Type (2017-2022)
5.2.2 Global Dihydroartemisinin Forecasted Revenue by Type (2023-2028)
5.2.3 Global Dihydroartemisinin Revenue Market Share by Type (2017-2028)
5.3 Global Dihydroartemisinin Price by Type
5.3.1 Global Dihydroartemisinin Price by Type (2017-2022)
5.3.2 Global Dihydroartemisinin Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Dihydroartemisinin Sales by Application
6.1.1 Global Dihydroartemisinin Historical Sales by Application (2017-2022)
6.1.2 Global Dihydroartemisinin Forecasted Sales by Application (2023-2028)
6.1.3 Global Dihydroartemisinin Sales Market Share by Application (2017-2028)
6.2 Global Dihydroartemisinin Revenue by Application
6.2.1 Global Dihydroartemisinin Historical Revenue by Application (2017-2022)
6.2.2 Global Dihydroartemisinin Forecasted Revenue by Application (2023-2028)
6.2.3 Global Dihydroartemisinin Revenue Market Share by Application (2017-2028)
6.3 Global Dihydroartemisinin Price by Application
6.3.1 Global Dihydroartemisinin Price by Application (2017-2022)
6.3.2 Global Dihydroartemisinin Price Forecast by Application (2023-2028)
7 North America
7.1 North America Dihydroartemisinin Sales Breakdown by Company
7.1.1 North America Dihydroartemisinin Sales by Company (2017-2022)
7.1.2 North America Dihydroartemisinin Revenue by Company (2017-2022)
7.2 North America Dihydroartemisinin Market Size by Type
7.2.1 North America Dihydroartemisinin Sales by Type (2017-2028)
7.2.2 North America Dihydroartemisinin Revenue by Type (2017-2028)
7.3 North America Dihydroartemisinin Market Size by Application
7.3.1 North America Dihydroartemisinin Sales by Application (2017-2028)
7.3.2 North America Dihydroartemisinin Revenue by Application (2017-2028)
7.4 North America Dihydroartemisinin Market Size by Country
7.4.1 North America Dihydroartemisinin Sales by Country (2017-2028)
7.4.2 North America Dihydroartemisinin Revenue by Country (2017-2028)
7.4.3 U.S.
7.4.4 Canada
8 Europe
8.1 Europe Dihydroartemisinin Sales Breakdown by Company
8.1.1 Europe Dihydroartemisinin Sales by Company (2017-2022)
8.1.2 Europe Dihydroartemisinin Revenue by Company (2017-2022)
8.2 Europe Dihydroartemisinin Market Size by Type
8.2.1 Europe Dihydroartemisinin Sales by Type (2017-2028)
8.2.2 Europe Dihydroartemisinin Revenue by Type (2017-2028)
8.3 Europe Dihydroartemisinin Market Size by Application
8.3.1 Europe Dihydroartemisinin Sales by Application (2017-2028)
8.3.2 Europe Dihydroartemisinin Revenue by Application (2017-2028)
8.4 Europe Dihydroartemisinin Market Size by Country
8.4.1 Europe Dihydroartemisinin Sales by Country (2017-2028)
8.4.2 Europe Dihydroartemisinin Revenue by Country (2017-2028)
8.4.3 Germany
8.4.4 France
8.4.5 U.K.
8.4.6 Italy
8.4.7 Russia
9 Asia Pacific
9.1 Asia Pacific Dihydroartemisinin Sales Breakdown by Company
9.1.1 Asia Pacific Dihydroartemisinin Sales by Company (2017-2022)
9.1.2 Asia Pacific Dihydroartemisinin Revenue by Company (2017-2022)
9.2 Asia Pacific Dihydroartemisinin Market Size by Type
9.2.1 Asia Pacific Dihydroartemisinin Sales by Type (2017-2028)
9.2.2 Asia Pacific Dihydroartemisinin Revenue by Type (2017-2028)
9.3 Asia Pacific Dihydroartemisinin Market Size by Application
9.3.1 Asia Pacific Dihydroartemisinin Sales by Application (2017-2028)
9.3.2 Asia Pacific Dihydroartemisinin Revenue by Application (2017-2028)
9.4 Asia Pacific Dihydroartemisinin Market Size by Region
9.4.1 Asia Pacific Dihydroartemisinin Sales by Region (2017-2028)
9.4.2 Asia Pacific Dihydroartemisinin Revenue by Region (2017-2028)
9.4.3 China
9.4.4 Japan
9.4.5 South Korea
9.4.6 India
9.4.7 Australia
9.4.8 Taiwan
9.4.9 Indonesia
9.4.10 Thailand
9.4.11 Malaysia
9.4.12 Philippines
10 Latin America
10.1 Latin America Dihydroartemisinin Sales Breakdown by Company
10.1.1 Latin America Dihydroartemisinin Sales by Company (2017-2022)
10.1.2 Latin America Dihydroartemisinin Revenue by Company (2017-2022)
10.2 Latin America Dihydroartemisinin Market Size by Type
10.2.1 Latin America Dihydroartemisinin Sales by Type (2017-2028)
10.2.2 Latin America Dihydroartemisinin Revenue by Type (2017-2028)
10.3 Latin America Dihydroartemisinin Market Size by Application
10.3.1 Latin America Dihydroartemisinin Sales by Application (2017-2028)
10.3.2 Latin America Dihydroartemisinin Revenue by Application (2017-2028)
10.4 Latin America Dihydroartemisinin Market Size by Country
10.4.1 Latin America Dihydroartemisinin Sales by Country (2017-2028)
10.4.2 Latin America Dihydroartemisinin Revenue by Country (2017-2028)
10.4.3 Mexico
10.4.4 Brazil
10.4.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Dihydroartemisinin Sales Breakdown by Company
11.1.1 Middle East and Africa Dihydroartemisinin Sales by Company (2017-2022)
11.1.2 Middle East and Africa Dihydroartemisinin Revenue by Company (2017-2022)
11.2 Middle East and Africa Dihydroartemisinin Market Size by Type
11.2.1 Middle East and Africa Dihydroartemisinin Sales by Type (2017-2028)
11.2.2 Middle East and Africa Dihydroartemisinin Revenue by Type (2017-2028)
11.3 Middle East and Africa Dihydroartemisinin Market Size by Application
11.3.1 Middle East and Africa Dihydroartemisinin Sales by Application (2017-2028)
11.3.2 Middle East and Africa Dihydroartemisinin Revenue by Application (2017-2028)
11.4 Middle East and Africa Dihydroartemisinin Market Size by Country
11.4.1 Middle East and Africa Dihydroartemisinin Sales by Country (2017-2028)
11.4.2 Middle East and Africa Dihydroartemisinin Revenue by Country (2017-2028)
11.4.3 Turkey
11.4.4 Saudi Arabia
11.4.5 U.A.E
12 Company Profiles
12.1 Sanofi
12.1.1 Sanofi Corporation Information
12.1.2 Sanofi Overview
12.1.3 Sanofi Dihydroartemisinin Sales, Revenue, Price and Gross Margin (2017-2022)
12.1.4 Sanofi Dihydroartemisinin Products and Services
12.1.5 Sanofi Dihydroartemisinin SWOT Analysis
12.1.6 Sanofi Recent Developments
12.2 KPC Pharmaceuticals
12.2.1 KPC Pharmaceuticals Corporation Information
12.2.2 KPC Pharmaceuticals Overview
12.2.3 KPC Pharmaceuticals Dihydroartemisinin Sales, Revenue, Price and Gross Margin (2017-2022)
12.2.4 KPC Pharmaceuticals Dihydroartemisinin Products and Services
12.2.5 KPC Pharmaceuticals Dihydroartemisinin SWOT Analysis
12.2.6 KPC Pharmaceuticals Recent Developments
12.3 Guangxi Xiancaotang Pharmaceutical
12.3.1 Guangxi Xiancaotang Pharmaceutical Corporation Information
12.3.2 Guangxi Xiancaotang Pharmaceutical Overview
12.3.3 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales, Revenue, Price and Gross Margin (2017-2022)
12.3.4 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Products and Services
12.3.5 Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin SWOT Analysis
12.3.6 Guangxi Xiancaotang Pharmaceutical Recent Developments
12.4 Guilin Pharmaceutical
12.4.1 Guilin Pharmaceutical Corporation Information
12.4.2 Guilin Pharmaceutical Overview
12.4.3 Guilin Pharmaceutical Dihydroartemisinin Sales, Revenue, Price and Gross Margin (2017-2022)
12.4.4 Guilin Pharmaceutical Dihydroartemisinin Products and Services
12.4.5 Guilin Pharmaceutical Dihydroartemisinin SWOT Analysis
12.4.6 Guilin Pharmaceutical Recent Developments
12.5 Kerui Nanhai Pharmaceutical
12.5.1 Kerui Nanhai Pharmaceutical Corporation Information
12.5.2 Kerui Nanhai Pharmaceutical Overview
12.5.3 Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales, Revenue, Price and Gross Margin (2017-2022)
12.5.4 Kerui Nanhai Pharmaceutical Dihydroartemisinin Products and Services
12.5.5 Kerui Nanhai Pharmaceutical Dihydroartemisinin SWOT Analysis
12.5.6 Kerui Nanhai Pharmaceutical Recent Developments
12.6 Shanghai Natural Bio-engineering Co
12.6.1 Shanghai Natural Bio-engineering Co Corporation Information
12.6.2 Shanghai Natural Bio-engineering Co Overview
12.6.3 Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales, Revenue, Price and Gross Margin (2017-2022)
12.6.4 Shanghai Natural Bio-engineering Co Dihydroartemisinin Products and Services
12.6.5 Shanghai Natural Bio-engineering Co Dihydroartemisinin SWOT Analysis
12.6.6 Shanghai Natural Bio-engineering Co Recent Developments
12.7 Novanat Bioresource
12.7.1 Novanat Bioresource Corporation Information
12.7.2 Novanat Bioresource Overview
12.7.3 Novanat Bioresource Dihydroartemisinin Sales, Revenue, Price and Gross Margin (2017-2022)
12.7.4 Novanat Bioresource Dihydroartemisinin Products and Services
12.7.5 Novanat Bioresource Dihydroartemisinin SWOT Analysis
12.7.6 Novanat Bioresource Recent Developments
12.8 Botanical Extracts EPZ Ltd
12.8.1 Botanical Extracts EPZ Ltd Corporation Information
12.8.2 Botanical Extracts EPZ Ltd Overview
12.8.3 Botanical Extracts EPZ Ltd Dihydroartemisinin Sales, Revenue, Price and Gross Margin (2017-2022)
12.8.4 Botanical Extracts EPZ Ltd Dihydroartemisinin Products and Services
12.8.5 Botanical Extracts EPZ Ltd Dihydroartemisinin SWOT Analysis
12.8.6 Botanical Extracts EPZ Ltd Recent Developments
13 Value Chain and Sales Channels Analysis
13.1 Dihydroartemisinin Value Chain Analysis
13.2 Dihydroartemisinin Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Dihydroartemisinin Production Mode & Process
13.4 Dihydroartemisinin Sales and Marketing
13.4.1 Dihydroartemisinin Sales Channels
13.4.2 Dihydroartemisinin Distributors
13.5 Dihydroartemisinin Customers
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Dihydroartemisinin Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Pharmaceutical Grade
Table 3. Major Manufacturers of Industrial Grade
Table 4. Global Dihydroartemisinin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Dihydroartemisinin Production by Region: 2017 VS 2021 VS 2028 (K MT)
Table 6. Global Dihydroartemisinin Production by Region (2017-2022) & (K MT)
Table 7. Global Dihydroartemisinin Production Market Share by Region (2017-2022)
Table 8. Global Dihydroartemisinin Production by Region (2023-2028) & (K MT)
Table 9. Global Dihydroartemisinin Production Market Share by Region (2023-2028)
Table 10. Dihydroartemisinin Market Trends
Table 11. Dihydroartemisinin Market Drivers
Table 12. Dihydroartemisinin Market Challenges
Table 13. Dihydroartemisinin Market Restraints
Table 14. Global Dihydroartemisinin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 15. Global Dihydroartemisinin Sales by Region (2017-2022) & (K MT)
Table 16. Global Dihydroartemisinin Sales Market Share by Region (2017-2022)
Table 17. Global Dihydroartemisinin Sales by Region (2023-2028) & (K MT)
Table 18. Global Dihydroartemisinin Sales Market Share by Region (2023-2028)
Table 19. Global Dihydroartemisinin Revenue by Region (2017-2022) & (US$ Million)
Table 20. Global Dihydroartemisinin Revenue Market Share by Region (2017-2022)
Table 21. Global Dihydroartemisinin Revenue by Region (2023-2028) & (US$ Million)
Table 22. Global Dihydroartemisinin Revenue Market Share by Region (2023-2028)
Table 23. Global Dihydroartemisinin Production Capacity by Manufacturers (2017-2022) & (K MT)
Table 24. Global Dihydroartemisinin Capacity Market Share by Manufacturers (2017-2022)
Table 25. Global Dihydroartemisinin Production by Manufacturers (2017-2022) & (K MT)
Table 26. Global Dihydroartemisinin Production Market Share by Manufacturers (2017-2022)
Table 27. Global Dihydroartemisinin Sales by Manufacturers (2017-2022) & (K MT)
Table 28. Global Dihydroartemisinin Sales Share by Manufacturers (2017-2022)
Table 29. Global Dihydroartemisinin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 30. Global Dihydroartemisinin Revenue Share by Manufacturers (2017-2022)
Table 31. Dihydroartemisinin Price by Manufacturers 2017-2022 (USD/MT)
Table 32. Global Dihydroartemisinin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Dihydroartemisinin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dihydroartemisinin as of 2021)
Table 34. Dihydroartemisinin Manufacturing Base Distribution and Headquarters
Table 35. Manufacturers Dihydroartemisinin Product Offered
Table 36. Date of Key Manufacturers Enter into Dihydroartemisinin Market
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Dihydroartemisinin Sales by Type (2017-2022) & (K MT)
Table 39. Global Dihydroartemisinin Sales by Type (2023-2028) & (K MT)
Table 40. Global Dihydroartemisinin Sales Share by Type (2017-2022)
Table 41. Global Dihydroartemisinin Sales Share by Type (2023-2028)
Table 42. Global Dihydroartemisinin Revenue by Type (2017-2022) & (US$ Million)
Table 43. Global Dihydroartemisinin Revenue by Type (2023-2028) & (US$ Million)
Table 44. Global Dihydroartemisinin Revenue Share by Type (2017-2022)
Table 45. Global Dihydroartemisinin Revenue Share by Type (2023-2028)
Table 46. Dihydroartemisinin Price by Type (2017-2022) & (USD/MT)
Table 47. Global Dihydroartemisinin Price Forecast by Type (2023-2028) & (USD/MT)
Table 48. Global Dihydroartemisinin Sales by Application (2017-2022) & (K MT)
Table 49. Global Dihydroartemisinin Sales by Application (2023-2028) & (K MT)
Table 50. Global Dihydroartemisinin Sales Share by Application (2017-2022)
Table 51. Global Dihydroartemisinin Sales Share by Application (2023-2028)
Table 52. Global Dihydroartemisinin Revenue by Application (2017-2022) & (US$ Million)
Table 53. Global Dihydroartemisinin Revenue by Application (2023-2028) & (US$ Million)
Table 54. Global Dihydroartemisinin Revenue Share by Application (2017-2022)
Table 55. Global Dihydroartemisinin Revenue Share by Application (2023-2028)
Table 56. Dihydroartemisinin Price by Application (2017-2022) & (USD/MT)
Table 57. Global Dihydroartemisinin Price Forecast by Application (2023-2028) & (USD/MT)
Table 58. North America Dihydroartemisinin Sales by Company (2017-2022) & (K MT)
Table 59. North America Dihydroartemisinin Sales Market Share by Company (2017-2022)
Table 60. North America Dihydroartemisinin Revenue by Company (2017-2022) & (US$ Million)
Table 61. North America Dihydroartemisinin Revenue Market Share by Company (2017-2022)
Table 62. North America Dihydroartemisinin Sales by Type (2017-2022) & (K MT)
Table 63. North America Dihydroartemisinin Sales by Type (2023-2028) & (K MT)
Table 64. North America Dihydroartemisinin Revenue by Type (2017-2022) & (US$ Million)
Table 65. North America Dihydroartemisinin Revenue by Type (2023-2028) & (US$ Million)
Table 66. North America Dihydroartemisinin Sales by Application (2017-2022) & (K MT)
Table 67. North America Dihydroartemisinin Sales by Application (2023-2028) & (K MT)
Table 68. North America Dihydroartemisinin Revenue by Application (2017-2022) & (US$ Million)
Table 69. North America Dihydroartemisinin Revenue by Application (2023-2028) & (US$ Million)
Table 70. North America Dihydroartemisinin Sales by Country (2017-2022) & (K MT)
Table 71. North America Dihydroartemisinin Sales by Country (2023-2028) & (K MT)
Table 72. North America Dihydroartemisinin Revenue by Country (2017-2022) & (US$ Million)
Table 73. North America Dihydroartemisinin Revenue by Country (2023-2028) & (US$ Million)
Table 74. Europe Dihydroartemisinin Sales by Company (2017-2022) & (K MT)
Table 75. Europe Dihydroartemisinin Sales Market Share by Company (2017-2022)
Table 76. Europe Dihydroartemisinin Revenue by Company (2017-2022) & (US$ Million)
Table 77. Europe Dihydroartemisinin Revenue Market Share by Company (2017-2022)
Table 78. Europe Dihydroartemisinin Sales by Type (2017-2022) & (K MT)
Table 79. Europe Dihydroartemisinin Sales by Type (2023-2028) & (K MT)
Table 80. Europe Dihydroartemisinin Revenue by Type (2017-2022) & (US$ Million)
Table 81. Europe Dihydroartemisinin Revenue by Type (2023-2028) & (US$ Million)
Table 82. Europe Dihydroartemisinin Sales by Application (2017-2022) & (K MT)
Table 83. Europe Dihydroartemisinin Sales by Application (2023-2028) & (K MT)
Table 84. Europe Dihydroartemisinin Revenue by Application (2017-2022) & (US$ Million)
Table 85. Europe Dihydroartemisinin Revenue by Application (2023-2028) & (US$ Million)
Table 86. Europe Dihydroartemisinin Sales by Country (2017-2022) & (K MT)
Table 87. Europe Dihydroartemisinin Sales by Country (2023-2028) & (K MT)
Table 88. Europe Dihydroartemisinin Revenue by Country (2017-2022) & (US$ Million)
Table 89. Europe Dihydroartemisinin Revenue by Country (2023-2028) & (US$ Million)
Table 90. Asia Pacific Dihydroartemisinin Sales by Company (2017-2022) & (K MT)
Table 91. Asia Pacific Dihydroartemisinin Sales Market Share by Company (2017-2022)
Table 92. Asia Pacific Dihydroartemisinin Revenue by Company (2017-2022) & (US$ Million)
Table 93. Asia Pacific Dihydroartemisinin Revenue Market Share by Company (2017-2022)
Table 94. Asia Pacific Dihydroartemisinin Sales by Type (2017-2022) & (K MT)
Table 95. Asia Pacific Dihydroartemisinin Sales by Type (2023-2028) & (K MT)
Table 96. Asia Pacific Dihydroartemisinin Revenue by Type (2017-2022) & (US$ Million)
Table 97. Asia Pacific Dihydroartemisinin Revenue by Type (2023-2028) & (US$ Million)
Table 98. Asia Pacific Dihydroartemisinin Sales by Application (2017-2022) & (K MT)
Table 99. Asia Pacific Dihydroartemisinin Sales by Application (2023-2028) & (K MT)
Table 100. Asia Pacific Dihydroartemisinin Revenue by Application (2017-2022) & (US$ Million)
Table 101. Asia Pacific Dihydroartemisinin Revenue by Application (2023-2028) & (US$ Million)
Table 102. Asia Pacific Dihydroartemisinin Sales by Region (2017-2022) & (K MT)
Table 103. Asia Pacific Dihydroartemisinin Sales by Region (2023-2028) & (K MT)
Table 104. Asia Pacific Dihydroartemisinin Revenue by Region (2017-2022) & (US$ Million)
Table 105. Asia Pacific Dihydroartemisinin Revenue by Region (2023-2028) & (US$ Million)
Table 106. Latin America Dihydroartemisinin Sales by Company (2017-2022) & (K MT)
Table 107. Latin America Dihydroartemisinin Sales Market Share by Company (2017-2022)
Table 108. Latin America Dihydroartemisinin Revenue by Company (2017-2022) & (US$ Million)
Table 109. Latin America Dihydroartemisinin Revenue Market Share by Company (2017-2022)
Table 110. Latin America Dihydroartemisinin Sales by Type (2017-2022) & (K MT)
Table 111. Latin America Dihydroartemisinin Sales by Type (2023-2028) & (K MT)
Table 112. Latin America Dihydroartemisinin Revenue by Type (2017-2022) & (US$ Million)
Table 113. Latin America Dihydroartemisinin Revenue by Type (2023-2028) & (US$ Million)
Table 114. Latin America Dihydroartemisinin Sales by Application (2017-2022) & (K MT)
Table 115. Latin America Dihydroartemisinin Sales by Application (2023-2028) & (K MT)
Table 116. Latin America Dihydroartemisinin Revenue by Application (2017-2022) & (US$ Million)
Table 117. Latin America Dihydroartemisinin Revenue by Application (2023-2028) & (US$ Million)
Table 118. Latin America Dihydroartemisinin Sales by Country (2017-2022) & (K MT)
Table 119. Latin America Dihydroartemisinin Sales by Country (2023-2028) & (K MT)
Table 120. Latin America Dihydroartemisinin Revenue by Country (2017-2022) & (US$ Million)
Table 121. Latin America Dihydroartemisinin Revenue by Country (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Dihydroartemisinin Sales by Company (2017-2022) & (K MT)
Table 123. Middle East and Africa Dihydroartemisinin Sales Market Share by Company (2017-2022)
Table 124. Middle East and Africa Dihydroartemisinin Revenue by Company (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Dihydroartemisinin Revenue Market Share by Company (2017-2022)
Table 126. Middle East and Africa Dihydroartemisinin Sales by Type (2017-2022) & (K MT)
Table 127. Middle East and Africa Dihydroartemisinin Sales by Type (2023-2028) & (K MT)
Table 128. Middle East and Africa Dihydroartemisinin Revenue by Type (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Dihydroartemisinin Revenue by Type (2023-2028) & (US$ Million)
Table 130. Middle East and Africa Dihydroartemisinin Sales by Application (2017-2022) & (K MT)
Table 131. Middle East and Africa Dihydroartemisinin Sales by Application (2023-2028) & (K MT)
Table 132. Middle East and Africa Dihydroartemisinin Revenue by Application (2017-2022) & (US$ Million)
Table 133. Middle East and Africa Dihydroartemisinin Revenue by Application (2023-2028) & (US$ Million)
Table 134. Middle East and Africa Dihydroartemisinin Sales by Country (2017-2022) & (K MT)
Table 135. Middle East and Africa Dihydroartemisinin Sales by Country (2023-2028) & (K MT)
Table 136. Middle East and Africa Dihydroartemisinin Revenue by Country (2017-2022) & (US$ Million)
Table 137. Middle East and Africa Dihydroartemisinin Revenue by Country (2023-2028) & (US$ Million)
Table 138. Sanofi Corporation Information
Table 139. Sanofi Description and Overview
Table 140. Sanofi Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 141. Sanofi Dihydroartemisinin Products and Services
Table 142. Sanofi Dihydroartemisinin SWOT Analysis
Table 143. Sanofi Recent Development
Table 144. KPC Pharmaceuticals Corporation Information
Table 145. KPC Pharmaceuticals Description and Overview
Table 146. KPC Pharmaceuticals Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 147. KPC Pharmaceuticals Dihydroartemisinin Products and Services
Table 148. KPC Pharmaceuticals Dihydroartemisinin SWOT Analysis
Table 149. KPC Pharmaceuticals Recent Development
Table 150. Guangxi Xiancaotang Pharmaceutical Corporation Information
Table 151. Guangxi Xiancaotang Pharmaceutical Description and Overview
Table 152. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 153. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin Products and Services
Table 154. Guangxi Xiancaotang Pharmaceutical Dihydroartemisinin SWOT Analysis
Table 155. Guangxi Xiancaotang Pharmaceutical Recent Development
Table 156. Guilin Pharmaceutical Corporation Information
Table 157. Guilin Pharmaceutical Description and Overview
Table 158. Guilin Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 159. Guilin Pharmaceutical Dihydroartemisinin Products and Services
Table 160. Guilin Pharmaceutical Dihydroartemisinin SWOT Analysis
Table 161. Guilin Pharmaceutical Recent Development
Table 162. Kerui Nanhai Pharmaceutical Corporation Information
Table 163. Kerui Nanhai Pharmaceutical Description and Overview
Table 164. Kerui Nanhai Pharmaceutical Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 165. Kerui Nanhai Pharmaceutical Dihydroartemisinin Products and Services
Table 166. Kerui Nanhai Pharmaceutical Dihydroartemisinin SWOT Analysis
Table 167. Kerui Nanhai Pharmaceutical Recent Development
Table 168. Shanghai Natural Bio-engineering Co Corporation Information
Table 169. Shanghai Natural Bio-engineering Co Description and Overview
Table 170. Shanghai Natural Bio-engineering Co Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 171. Shanghai Natural Bio-engineering Co Dihydroartemisinin Products and Services
Table 172. Shanghai Natural Bio-engineering Co Dihydroartemisinin SWOT Analysis
Table 173. Shanghai Natural Bio-engineering Co Recent Development
Table 174. Novanat Bioresource Corporation Information
Table 175. Novanat Bioresource Description and Overview
Table 176. Novanat Bioresource Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 177. Novanat Bioresource Dihydroartemisinin Products and Services
Table 178. Novanat Bioresource Dihydroartemisinin SWOT Analysis
Table 179. Novanat Bioresource Recent Development
Table 180. Botanical Extracts EPZ Ltd Corporation Information
Table 181. Botanical Extracts EPZ Ltd Description and Overview
Table 182. Botanical Extracts EPZ Ltd Dihydroartemisinin Sales (K MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2017-2022)
Table 183. Botanical Extracts EPZ Ltd Dihydroartemisinin Products and Services
Table 184. Botanical Extracts EPZ Ltd Dihydroartemisinin SWOT Analysis
Table 185. Botanical Extracts EPZ Ltd Recent Development
Table 186. Key Raw Materials Lists
Table 187. Raw Materials Key Suppliers Lists
Table 188. Dihydroartemisinin Distributors List
Table 189. Dihydroartemisinin Customers List
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Dihydroartemisinin Product Picture
Figure 2. Global Dihydroartemisinin Market Share by Type in 2021 & 2028
Figure 3. Pharmaceutical Grade Product Picture
Figure 4. Industrial Grade Product Picture
Figure 5. Global Dihydroartemisinin Market Share by Application in 2021 & 2028
Figure 6. Malaria Treatment
Figure 7. Scientific Research
Figure 8. Others
Figure 9. Dihydroartemisinin Report Years Considered
Figure 10. Global Dihydroartemisinin Capacity, Production and Utilization (2017-2028) & (K MT)
Figure 11. Global Dihydroartemisinin Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 12. Global Dihydroartemisinin Production Market Share by Region (2017-2022)
Figure 13. Global Dihydroartemisinin Production Market Share by Region (2023-2028)
Figure 14. Dihydroartemisinin Production Growth Rate in North America (2017-2028) & (K MT)
Figure 15. Dihydroartemisinin Production Growth Rate in Europe (2017-2028) & (K MT)
Figure 16. Dihydroartemisinin Production Growth Rate in Japan (2017-2028) & (K MT)
Figure 17. Dihydroartemisinin Production Growth Rate in China (2017-2028) & (K MT)
Figure 18. Dihydroartemisinin Production Growth Rate in South Korea (2017-2028) & (K MT)
Figure 19. Dihydroartemisinin Production Growth Rate in India (2017-2028) & (K MT)
Figure 20. Global Dihydroartemisinin Sales 2017-2028 (K MT)
Figure 21. Global Dihydroartemisinin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 22. Global Dihydroartemisinin Revenue 2017-2028 (US$ Million)
Figure 23. Global Dihydroartemisinin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 24. Global Dihydroartemisinin Sales Market Share by Region (20

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Dihydroartemisinin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 88

The global Dihydroartemisinin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Dihydroartemisinin is estimated to increase from $ million in 2023 to reach $ million by 2......

Global Artemisinin Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114

According to our LPI (LP Information) latest study, the global Artemisinin market size was valued at US$ 61 million in 2023. With growing demand in downstream market, the Artemisinin is forecast to a readjusted size of US$ 227 million by 2030 with a CAGR of 20.7% during review period. The research report highlights the growth potential of the global Artemisinin market. Artemisinin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......

Global Drugs for Malaria Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90

According to our LPI (LP Information) latest study, the global Drugs for Malaria market size was valued at US$ million in 2023. With growing demand in downstream market, the Drugs for Malaria is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Drugs for Malaria market. Drugs for Malaria are expected to show stable growth in the future market. However, product differentiation, reduc......

Dihydroartemisinin - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 99

The global Dihydroartemisinin market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dihydroartemisinin in various end use industries. The expanding demands from the Malaria Treatment, Scientific Research and Others,, are propelling Dihydroartemisinin market. Pharmaceutical Grade, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......

Global Drugs For Malaria Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 05-Dec-2023        Price: US 3380 Onwards        Pages: 100

Market Overview of Global Drugs For Malaria market: According to our latest research, the global Drugs For Malaria market looks promising in the next 5 years. As of 2022, the global Drugs For Malaria market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. It is Anti-malarial drug. Anti-malarial drugs are the medicines used to prevent and treat malaria. The malaria is the disease caused due to ......

Global Artemisinin Professional Survey Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 3280 Onwards        Pages: 105

Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......

Global Artemisinin Market Research Report 2023, Forecast to 2028

Published: 15-Nov-2023        Price: US 2680 Onwards        Pages: 131

Artemisinin and its semisynthetic derivatives are a group of drugs used in the treatment of malaria due to Plasmodium falciparum. It was discovered in 1972 by Tu Youyou, who shared the 2015 Nobel Prize in Physiology or Medicine for her discovery. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clie......

Global Dihydroartemisinin Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 127

Market Overview of Global Dihydroartemisinin market: According to our latest research, the global Dihydroartemisinin market looks promising in the next 5 years. As of 2022, the global Dihydroartemisinin market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Dihydroartemisini......

Global Artemisinin Market Insights, Forecast to 2029

Published: 20-Sep-2023        Price: US 4900 Onwards        Pages: 108

Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast. The global Artemisinin market is projected to grow from US$ 75 million in 2023 to US$ 225.3 million by 2029, at a Compound Annual Growth Rate......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs